HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SKB BIO-B

423.200

+3.0000.71%

Volume:354.01K

Turnover:151.49M

Market Cap:98.68B

PE:-351.62

High:439.600

Open:412.000

Low:410.800

Close:420.200

52wk High:581.000

52wk Low:171.100

Shares:233.19M

HK Float Shares:162.77M

Volume Ratio:0.73

T/O Rate:0.22%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.204

ROE:-17.56%

ROA:-9.92%

PB:17.46

PE(LYR):-351.62

PS:58.35

Loading ...

Overview Company News Filings

BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says Trop2 Adc Sacituzumab Tirumotecan Approved For Marketing For Fourth Indication By China's NMPA

Kelun-Biotech Announces Fourth Indication for Sacituzumab Tirumotecan (Sac-TMT) Approved by Nmpa in Hr+/Her2- Breast Cancer

THOMSON REUTERS

Sichuan Kelun-Biotech (6990) Announces Fourth NMPA Approval of TROP2 ADC Sacituzumab Tirumotecan for Advanced HR+/HER2- Breast Cancer

Bulletin Express

SKB BIO-B's Core TROP2 ADC Therapy Sac-TMT Gains Fourth Indication Approval in China for HR+/HER2- Breast Cancer

Sichuan Kelun-Biotech Biopharmaceutical - Trop2 ADC Sacituzumab Tirumotecan Approved for Marketing for Fourth Indication by Nmpa

THOMSON REUTERS

Sichuan Kelun-Biotech Receives NMPA Approval for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer

Kelun-Biotech (06990) Releases January 2026 Monthly Return

Bulletin Express

Sichuan Kelun-Biotech Renews R&D Procurement Deal With China Resources Kelun; Shares Slip 5%

MT Newswires Live

Does Breakthrough Status For Sacituzumab Tirumotecan-Keytruda Combo Reshape Kelun-Biotech’s Oncology Strategy (SEHK:6990)?

Simply Wall St.

Kelun-Biotech Releases Latest Corporate Presentation Document

Why Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) Is Up 18.9% After Breakthrough ADC Milestones And Global Tie-Up

Simply Wall St.

Kelun-Bota Biotech-B (06990) Terminates Subscription of 980 Million Yuan Bank of China Structured Deposit

BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says Subscription For BOC Structured Deposit II Terminated

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Subscription for BOC Structured Deposit Ii Terminated

THOMSON REUTERS

Kelun-Biotech to Present Business Progress and Innovation Strategies at J.P. Morgan Healthcare Conference

Kelun-Biotech to Attend the 44TH J.p. Morgan Healthcare Conference, Sharing Its Business Progresses and Innovation Strategies

THOMSON REUTERS

Sichuan Kelun-Biotech Subscribes to Wealth Management Products

MT Newswires Live

BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Subscribes For Wealth Management Products

SKB BIO-B (06990) Subscribes to Financial Products

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Subscriptions for Wealth Management Products

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/06990/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"SKB BIO-B","latestPrice":423.2,"timestamp":1770365284006,"preClose":420.2,"halted":0,"volume":354009,"delay":0,"changeRate":0.007139457401237506,"floatShares":162769979,"shares":233185969,"eps":-1.203559,"marketStatus":"Market Closed","change":3,"latestTime":"02-06 16:08:04","open":412,"high":439.6,"low":410.8,"amount":151490806,"amplitude":0.068539,"askPrice":423.2,"askSize":1200,"bidPrice":421,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-3.508831,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":7,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":420.2,"openAndCloseTimeList":[[1770341400000,1770350400000],[1770354000000,1770364800000]],"volumeRatio":0.7264703466449586,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":162769979,"roa":"-9.92%","roe":"-17.56%","lyrEps":-1.203559,"volumeRatio":0.7264703466449586,"shares":233185969,"dividePrice":0,"high":439.6,"amplitude":0.068539,"preClose":420.2,"low":410.8,"week52Low":171.1,"pbRate":"17.46","psRate":"58.35","week52High":581,"institutionHeld":0,"latestPrice":423.2,"committee":-0.411765,"eps":-1.203559,"divideRate":0,"volume":354009,"delay":0,"ttmEps":-3.508831,"open":412,"prevYearClose":392.2,"prevWeekClose":415.4,"prevMonthClose":415.4,"prevQuarterClose":392.2,"fiveDayClose":415.4,"twentyDayClose":476.4,"sixtyDayClose":412.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2025-08-18","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post Market","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"Post Market","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-03-25","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null},{"date":"2023-08-28","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693186200000,"name":null,"time":"","dateTimestamp":1693152000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3684,"buy":0.5263,"hold":0.1053,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5263,"analysts":19,"updateTime":1764777600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2026-02-06","current":-120.60997,"percent":0.53605,"low":-351.800852,"twenty":-172.20913,"median":-127.906249,"eighty":-50.304899,"high":-21.029201,"avg":-126.717538,"sd":78.434203,"marketCap":98684302080},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200},{"date":"2025-04-25","current":-235.137362,"twenty":-160.624501,"median":-68.953584,"eighty":-45.131919,"marketCap":66771338400},{"date":"2025-05-02","current":-274.570331,"twenty":-161.195254,"median":-69.468586,"eighty":-45.197413,"marketCap":78134738400},{"date":"2025-05-09","current":-249.374354,"twenty":-161.514906,"median":-70.050704,"eighty":-45.202208,"marketCap":71462875059},{"date":"2025-05-16","current":-247.507619,"twenty":-162.87029,"median":-70.732965,"eighty":-45.217068,"marketCap":71507400214},{"date":"2025-05-23","current":-244.618313,"twenty":-163.824551,"median":-71.32983,"eighty":-45.58151,"marketCap":70884048033},{"date":"2025-05-30","current":-244.159494,"twenty":-165.025774,"median":-71.669987,"eighty":-45.601984,"marketCap":71062148656},{"date":"2025-06-06","current":-258.187076,"twenty":-166.004403,"median":-72.203519,"eighty":-46.006494,"marketCap":75336563613},{"date":"2025-06-13","current":-271.678883,"twenty":-167.701589,"median":-72.488214,"eighty":-46.133909,"marketCap":79304691313},{"date":"2025-06-20","current":-252.757485,"twenty":-168.349452,"median":-72.789206,"eighty":-46.315126,"marketCap":73636805593},{"date":"2025-06-27","current":-255.806605,"twenty":-169.647858,"median":-73.569836,"eighty":-46.457129,"marketCap":74733815733},{"date":"2025-07-04","current":-283.173205,"twenty":-171.495185,"median":-73.869687,"eighty":-46.685504,"marketCap":82732847998},{"date":"2025-07-11","current":-266.231967,"twenty":-173.142078,"median":-74.539848,"eighty":-46.749361,"marketCap":77704884860},{"date":"2025-07-18","current":-304.526119,"twenty":-187.755426,"median":-75.01675,"eighty":-46.798833,"marketCap":88812112519},{"date":"2025-07-25","current":-289.211949,"twenty":-196.095673,"median":-75.38559,"eighty":-46.877904,"marketCap":84652615741},{"date":"2025-08-01","current":-318.351212,"twenty":-209.071662,"median":-75.715906,"eighty":-46.908544,"marketCap":92605939250},{"date":"2025-08-08","current":-315.832709,"twenty":-214.487876,"median":-76.34536,"eighty":-47.149906,"marketCap":92103142937},{"date":"2025-08-15","current":-340.637946,"twenty":-221.73884,"median":-77.157567,"eighty":-47.354138,"marketCap":99188000086},{"date":"2025-08-22","current":-135.707825,"twenty":-221.73884,"median":-78.335478,"eighty":-47.421279,"marketCap":106638527281},{"date":"2025-08-29","current":-131.473703,"twenty":-217.466422,"median":-78.819337,"eighty":-47.438439,"marketCap":103804584421},{"date":"2025-09-05","current":-151.82862,"twenty":-215.82299,"median":-80.340969,"eighty":-47.449348,"marketCap":119756940196},{"date":"2025-09-12","current":-146.494298,"twenty":-214.791029,"median":-81.555855,"eighty":-47.474394,"marketCap":115757424063},{"date":"2025-09-19","current":-147.466634,"twenty":-214.487876,"median":-85.53437,"eighty":-47.73502,"marketCap":116443055400},{"date":"2025-09-26","current":-143.954691,"twenty":-214.295448,"median":-89.950081,"eighty":-47.938811,"marketCap":113375018127},{"date":"2025-10-03","current":-165.853778,"twenty":-213.463042,"median":-128.34687,"eighty":-48.070155,"marketCap":130933921593},{"date":"2025-10-10","current":-144.531455,"twenty":-212.219938,"median":-131.729362,"eighty":-48.217901,"marketCap":113934664453},{"date":"2025-10-17","current":-135.703716,"twenty":-210.108236,"median":-132.867642,"eighty":-48.374971,"marketCap":106892448189},{"date":"2025-10-24","current":-129.499037,"twenty":-207.014216,"median":-133.546653,"eighty":-48.434282,"marketCap":102042180034},{"date":"2025-10-31","current":-132.379263,"twenty":-204.550971,"median":-132.326202,"eighty":-48.483234,"marketCap":104467314112},{"date":"2025-11-07","current":-120.930715,"twenty":-203.710245,"median":-131.985022,"eighty":-48.610423,"marketCap":95373061321},{"date":"2025-11-14","current":-137.099974,"twenty":-201.138492,"median":-131.729362,"eighty":-48.622244,"marketCap":108431475585},{"date":"2025-11-21","current":-125.836792,"twenty":-194.360264,"median":-130.233026,"eighty":-48.651606,"marketCap":99477134375},{"date":"2025-11-28","current":-134.139839,"twenty":-194.090443,"median":-131.64896,"eighty":-48.675637,"marketCap":106426076251},{"date":"2025-12-05","current":-134.965867,"twenty":-192.863217,"median":-131.473703,"eighty":-48.751223,"marketCap":107265545740},{"date":"2025-12-12","current":-128.449432,"twenty":-188.527876,"median":-130.526276,"eighty":-48.814858,"marketCap":102275366003},{"date":"2025-12-19","current":-122.479247,"twenty":-187.446049,"median":-129.499037,"eighty":-48.911385,"marketCap":97751558204},{"date":"2025-12-24","current":-122.098928,"twenty":-187.290368,"median":-128.758533,"eighty":-48.913338,"marketCap":97751558204},{"date":"2026-01-02","current":-116.223952,"twenty":-179.729041,"median":-128.478737,"eighty":-49.104524,"marketCap":93414299181},{"date":"2026-01-09","current":-137.872108,"twenty":-173.799059,"median":-128.508043,"eighty":-49.251224,"marketCap":111089795631},{"date":"2026-01-16","current":-136.67551,"twenty":-173.152374,"median":-129.252083,"eighty":-49.296233,"marketCap":110483512112},{"date":"2026-01-23","current":-124.044288,"twenty":-172.874196,"median":-128.511935,"eighty":-49.590244,"marketCap":100176692282},{"date":"2026-01-30","current":-119.398299,"twenty":-172.654145,"median":-128.43808,"eighty":-50.08289,"marketCap":96865451522},{"date":"2026-02-06","current":-121.3325,"twenty":-172.20913,"median":-127.906249,"eighty":-50.304899,"marketCap":98684302080}],"updateTime":1770445890784},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609564818","title":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says Trop2 Adc Sacituzumab Tirumotecan Approved For Marketing For Fourth Indication By China's NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2609564818","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609564818?lang=en_us&edition=fundamental","pubTime":"2026-02-06 18:33","pubTimestamp":1770374008,"startTime":"0","endTime":"0","summary":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says Trop2 Adc Sacituzumab Tirumotecan Approved For Marketing For Fourth Indication By China's NMPAFeb 6  - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd 6990.HK:TROP2 ADC SACITUZUMAB TIRUMOTECAN APPROVED FOR MARKETING FOR FOURTH INDICATION BY NMPAFurther company coverage: 6990.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nFWN3Z122A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2609565148","title":"Kelun-Biotech Announces Fourth Indication for Sacituzumab Tirumotecan (Sac-TMT) Approved by Nmpa in Hr+/Her2- Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2609565148","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609565148?lang=en_us&edition=fundamental","pubTime":"2026-02-06 17:00","pubTimestamp":1770368400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nTUA8VLKFG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"1150343342","title":"Sichuan Kelun-Biotech (6990) Announces Fourth NMPA Approval of TROP2 ADC Sacituzumab Tirumotecan for Advanced HR+/HER2- Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1150343342","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150343342?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:44","pubTimestamp":1770367456,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (Stock Code: 6990) announced that the National Medical Products Administration (NMPA) of China has approved a new indication for sacituzumab...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"gpt_icon":0},{"id":"1148301809","title":"SKB BIO-B's Core TROP2 ADC Therapy Sac-TMT Gains Fourth Indication Approval in China for HR+/HER2- Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1148301809","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148301809?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:41","pubTimestamp":1770367273,"startTime":"0","endTime":"0","summary":"SKB BIO-B (06990) announced that its TROP2-targeting antibody-drug conjugate (ADC), sacituzumab govitecan (sac-TMT, also known as SKB264/MK-2870), has received approval from China's National Medical...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU0196878994.USD","HR","BK4203","BK4225","06990"],"gpt_icon":0},{"id":"2609563682","title":"Sichuan Kelun-Biotech Biopharmaceutical - Trop2 ADC Sacituzumab Tirumotecan Approved for Marketing for Fourth Indication by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2609563682","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609563682?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:34","pubTimestamp":1770366894,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nFWN3Z122A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2609635275","title":"Sichuan Kelun-Biotech Receives NMPA Approval for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2609635275","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609635275?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:33","pubTimestamp":1770366831,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. announced that its TROP2-directed antibody-drug conjugate , sacituzumab tirumotecan , has been approved by the National Medical Products Administration  of China for a new indication. The approval covers the treatment of adult patients with unresectable or metastatic hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative  breast cancer who have received at least one prior systemic therapy. This marks the fourth approved indication for sac-TMT by the NMPA.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL47X09v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064130708.USD","BK1161","LU1934453819.USD","LU1064131003.USD","002422","LU2148510915.USD","LU1979443071.USD","BK0239","06990","BK0060","LU0196878994.USD"],"gpt_icon":0},{"id":"1117718675","title":"Kelun-Biotech (06990) Releases January 2026 Monthly Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1117718675","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117718675?lang=en_us&edition=fundamental","pubTime":"2026-02-04 16:47","pubTimestamp":1770194858,"startTime":"0","endTime":"0","summary":"Kelun-Biotech (06990) disclosed its monthly return for the period ended 31 January 2026. The company’s total authorized share capital stood at RMB 233,185,969, reflecting no change during the month....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"gpt_icon":0},{"id":"2604902191","title":"Sichuan Kelun-Biotech Renews R&D Procurement Deal With China Resources Kelun; Shares Slip 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604902191","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604902191?lang=en_us&edition=fundamental","pubTime":"2026-01-19 12:54","pubTimestamp":1768798473,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical  entered into a new transaction framework to procure R&D-related goods from China Resources Kelun  Medicine, according to a Jan. 16 Hong Kong bourse filing.Shares of the biopharmaceutical firm were down over 5% in Monday's midday trade.The agreement covers the procurement of R&D-related drugs, consumables, and fixed assets for a term ending Dec. 31, 2028.It replaces a previous framework agreement that expired at the end of 2025.Kelun-Biotech set annual caps of nearly 10.7 million yuan for each of 2026, 2027, and 2028, the filing showed.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2604944685","title":"Does Breakthrough Status For Sacituzumab Tirumotecan-Keytruda Combo Reshape Kelun-Biotech’s Oncology Strategy (SEHK:6990)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2604944685","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604944685?lang=en_us&edition=fundamental","pubTime":"2026-01-17 12:34","pubTimestamp":1768624447,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical recently announced that its TROP2-directed ADC sacituzumab tirumotecan, combined with MSD’s KEYTRUDA, received Breakthrough Therapy Designation in China for first-line treatment of certain advanced non-small cell lung cancer patients, while its CEO highlighted pipeline progress and globalisation plans at the J.P. Morgan Healthcare Conference.\nThe clustering of multiple Breakthrough Therapy Designations around sacituzumab tirumotecan, alongside...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/does-breakthrough-status-for-sacituzumab-tirumotecan-keytrud","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/does-breakthrough-status-for-sacituzumab-tirumotecan-keytrud","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2023250504.SGD","LU1093756168.USD","LU0234572021.USD","LU1929549753.HKD","SG9999014575.USD","LU0985320562.USD","LU1917777945.USD","LU1035773651.USD","IE00BJT1NW94.SGD","LU1201861249.SGD","IE00BLSP4452.SGD","IE000M9KFDE8.USD","IE00B4R5TH58.HKD","LU2324357040.USD","LU1934455277.USD","LU0980610538.SGD","LU0211331839.USD","LU0266013472.USD","LU0965509283.SGD","LU0106261372.USD","IE00B1BXHZ80.USD","LU0648001328.SGD","LU1066053197.SGD","LU2461242641.AUD","SG9999002232.USD","BK4533","IE00B2B36J28.USD","LU0006306889.USD","LU1066051225.USD","BK4516","BK4534","LU2125154778.USD","LU1934455194.USD","IE0009355771.USD","LU0203345920.USD","SG9999014559.SGD","BK4007","LU2361044865.SGD","LU1934455863.HKD","LU1571399168.USD","LU1989771016.USD","LU0320765489.SGD","LU2089984988.USD","LU0965509101.SGD","LU1983299246.USD","IE00BLSP4239.USD","IE0002141913.USD","LU0196878994.USD","LU1066051498.USD","LU2361045086.USD","LU0238689110.USD","LU1116320737.USD","LU2361044949.HKD","LU0070302665.USD","LU1585245621.USD","LU1057294990.SGD","LU0122379950.USD","LU1941712264.USD","SG9999015341.SGD","LU0130517989.USD","BK4550","SG9999015358.SGD","LU0208291251.USD","IE00BFTCPJ56.SGD","LU2360032135.SGD","06990","LU1093756325.SGD","LU1699723380.USD","IE00BJJMRZ35.SGD","LU1066051811.HKD","LU0477156953.USD","LU2106854487.HKD","LU1941712348.USD","LU1974910355.USD","SG9999002224.SGD","IE00BSNM7G36.USD","BK4559","LU2023250843.SGD","BK1161","IE00BN8TJ469.HKD","LU2125154935.USD","LU0058720904.USD","LU0320765646.SGD","SG9999001176.USD","LU1116320901.HKD","LU1061106388.HKD","LU0289739699.SGD","SG9999014567.USD","LU0965509010.AUD","LU0130102774.USD","LU1037948541.HKD","LU1069347547.HKD","SG9999014542.SGD","IE00BBT3K403.USD","LU0098860793.USD","LU1162221912.USD","LU1430594728.SGD","LU0265550359.USD","SG9999013999.USD","BK4588","SG9999001176.SGD","LU1989772923.USD","SG9999001440.SGD","LU0265550946.USD","LU1023059063.AUD","LU0861579265.USD","LU2112291526.USD","SGXZ57979304.SGD","LU2468319806.SGD","LU0203347892.USD","LU0965508806.USD","BK4585","LU1291159041.SGD","LU1989772840.SGD","LU1037948897.HKD"],"gpt_icon":0},{"id":"2603980939","title":"Kelun-Biotech Releases Latest Corporate Presentation Document","url":"https://stock-news.laohu8.com/highlight/detail?id=2603980939","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603980939?lang=en_us&edition=fundamental","pubTime":"2026-01-16 02:30","pubTimestamp":1768501819,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has published the presentation materials from the 44th J.P. Morgan Healthcare Conference. For more details, please refer to the \"Investor Relations-Investor Calendar\" page of the company's official website: Investor Relations-Investor Calendar.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. published the original content used to generate this news brief via PR Newswire  on January 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL9MB0xr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK0239","LU2148510915.USD","BK0060","LU0196878994.USD","BK1161","LU1064131003.USD","LU1979443071.USD","LU1064130708.USD","LU1934453819.USD","002422"],"gpt_icon":0},{"id":"2602300920","title":"Why Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) Is Up 18.9% After Breakthrough ADC Milestones And Global Tie-Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2602300920","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602300920?lang=en_us&edition=fundamental","pubTime":"2026-01-10 01:19","pubTimestamp":1767979187,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical recently reported that its TROP2-directed ADC sacituzumab tirumotecan, combined with pembrolizumab, received Breakthrough Therapy Designation in China for first-line PD-L1-positive NSCLC, while its ITGB6-targeted ADC SKB105 secured IND approval for advanced solid tumors and a new global collaboration with Crescent Biopharma was announced.\nThese developments, alongside multiple ongoing registrational and Phase 3 trials and structured distribution and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/why-sichuan-kelun-biotech-biopharmaceutical-sehk6990-is-up-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/why-sichuan-kelun-biotech-biopharmaceutical-sehk6990-is-up-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4080","BK4231","LU0196878994.USD","06990","BK1161","ADC"],"gpt_icon":0},{"id":"1116767445","title":"Kelun-Bota Biotech-B (06990) Terminates Subscription of 980 Million Yuan Bank of China Structured Deposit","url":"https://stock-news.laohu8.com/highlight/detail?id=1116767445","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116767445?lang=en_us&edition=fundamental","pubTime":"2026-01-07 22:53","pubTimestamp":1767797582,"startTime":"0","endTime":"0","summary":"Kelun-Bota Biotech-B (06990) announced the termination of its subscription to a Bank of China structured deposit II with a principal amount of RMB 980 million. The company ended this subscription on...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1522347837.USD","BK0183","LU1051769294.HKD","LU0651947912.USD","LU2097828805.USD","601988","BK0012","LU0651946864.USD","IE00BQJZWZ67.USD","03143","LU1497733557.USD","03988","LU2097828631.EUR","SG9999001093.SGD","LU2097828714.EUR","LU1282651121.HKD","LU1497733631.SGD","BK1560","LU0348805143.USD","LU2097828474.EUR","BK0015","LU1282651048.USD","BK0028","LU0072462343.USD","LU1634259557.SGD","BK1231","BK1161","BK1521","LU2097828557.USD","IE00B19Z5X02.USD","LU0307460666.USD","SG9999006597.SGD","LU0293314216.USD","LU1497734951.SGD","LU1051768304.USD","LU1634259391.SGD","LU0588546209.SGD","LU1048588211.SGD","LU1224444064.USD","LU0196878994.USD","BK0188","IE00BWDBJ730.SGD","LU1515016050.SGD","06990","BK0278"],"gpt_icon":0},{"id":"2601889804","title":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says Subscription For BOC Structured Deposit II Terminated","url":"https://stock-news.laohu8.com/highlight/detail?id=2601889804","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601889804?lang=en_us&edition=fundamental","pubTime":"2026-01-07 22:51","pubTimestamp":1767797468,"startTime":"0","endTime":"0","summary":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says Subscription For BOC Structured Deposit II TerminatedJan 7 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd 6990.HK:SUBSCRIPTION FOR BOC ST","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nFWN3Y80DG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2601801797","title":"Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Subscription for BOC Structured Deposit Ii Terminated","url":"https://stock-news.laohu8.com/highlight/detail?id=2601801797","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601801797?lang=en_us&edition=fundamental","pubTime":"2026-01-07 22:47","pubTimestamp":1767797242,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nFWN3Y80DG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2601281568","title":"Kelun-Biotech to Present Business Progress and Innovation Strategies at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2601281568","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601281568?lang=en_us&edition=fundamental","pubTime":"2026-01-07 10:45","pubTimestamp":1767753902,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is set to attend the 44th J.P. Morgan Healthcare Conference in San Francisco, California, from January 12 to 15, 2026. Dr. Michael Ge, President and CEO of Kelun-Biotech, will deliver a presentation on Thursday, January 15, 2026, at 9:30 AM Pacific Standard Time at the Westin St. Francis. The company will share its latest business progress and innovation strategies, and explore partnership opportunities at this major global healthcare industry event. A live webcast of the presentation will be available on Kelun-Biotech's official website, along with a replay for 30 days following the conference.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sichuan Kelun-Biotech Biopharmaceutical Co., ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDLbrDM1S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934453819.USD","002422","LU0196878994.USD","BK1161","LU1064131003.USD","LU1979443071.USD","LU2148510915.USD","LU1064130708.USD","BK0060","06990","BK0239"],"gpt_icon":0},{"id":"2601828938","title":"Kelun-Biotech to Attend the 44TH J.p. Morgan Healthcare Conference, Sharing Its Business Progresses and Innovation Strategies","url":"https://stock-news.laohu8.com/highlight/detail?id=2601828938","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601828938?lang=en_us&edition=fundamental","pubTime":"2026-01-07 10:44","pubTimestamp":1767753890,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUA5J2JZC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2023250330.USD","LU0820562030.AUD","LU1244550494.USD","LU1548497426.USD","LU1914381329.SGD","LU0267386448.USD","BK4581","LU2237443978.SGD","LU2746668974.SGD","LU2746668461.USD","LU1974910355.USD","LU2756315664.SGD","LU0942090050.USD","LU2054465674.USD","LU0640476718.USD","LU2456880835.USD","LU1496350502.SGD","BK4534","IE00BYXW3230.USD","LU2462157665.USD","IE00BLSP4239.USD","IE00BBT3K403.USD","IE00BJLML261.HKD","LU2756315318.SGD","LU0345770308.USD","IE00BZ1G4Q59.USD","LU0211327993.USD","LU0256863811.USD","LU0868494708.USD","LU1267930490.SGD","LU0211326839.USD","06990","LU0203347892.USD","LU1668664300.SGD","BK4533","LU2213496289.HKD","LU1064131342.USD","LU1917777945.USD","LU1670628061.USD","LU1720051017.SGD","BK4516","LU0234572021.USD","LU0868494617.USD","LU2242649171.HKD","LU0943347566.SGD","IE00B1BXHZ80.USD","LU0106261372.USD","LU0265550359.USD","LU2023250843.SGD","LU0208291251.USD"],"gpt_icon":0},{"id":"2601840794","title":"Sichuan Kelun-Biotech Subscribes to Wealth Management Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2601840794","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601840794?lang=en_us&edition=fundamental","pubTime":"2026-01-07 10:22","pubTimestamp":1767752534,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical  subscribed to wealth management products from Bank of China  and Bank of Communications , according to a Hong Kong bourse filing Tuesday.Shares of the drug company gained over 2% in morning trade Wednesday.The firm invested 980 million yuan in a structured deposit with Bank of China for a 181-day period. The product offers an annualized floating rate of return of 0.80% or 2.15% per annum.Meanwhile, the company invested 400 million yuan in a structured deposit with Bank of Communications for a 182-day period. The product offers an annualized floating rate of return of 1.2% or 2.03% per annum.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0196878994.USD","LU1497734951.SGD","LU2097828805.USD","SG9999006597.SGD","LU0307460666.USD","LU2097828557.USD","LU1051769294.HKD","601328","06990","LU0293314216.USD","IE00B19Z5X02.USD","BK0020","LU1282651121.HKD","BK0188","SG9999001093.SGD","BK1161","BK0187","LU1048588211.SGD","03328","BK0015","BK0028","LU0588546209.SGD","LU1515016050.SGD","BK1231","LU1634259557.SGD","LU0651946864.USD","03988","LU1634259391.SGD","LU2097828714.EUR","LU2097828474.EUR","LU1051768304.USD","LU0072462343.USD","BK0183","BK1560","LU2097828631.EUR","03143","LU0651947912.USD","LU1497733557.USD","IE00BWDBJ730.SGD","BK0012","LU0348805143.USD","LU1282651048.USD","IE00BQJZWZ67.USD","LU1497733631.SGD","BK0278","BK1521","LU1224444064.USD","SG9999001226.SGD","LU1522347837.USD","601988"],"gpt_icon":0},{"id":"2601881880","title":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Subscribes For Wealth Management Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2601881880","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601881880?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:52","pubTimestamp":1767707530,"startTime":"0","endTime":"0","summary":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Subscribes For Wealth Management ProductsJan 6 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd 6990.HK:SUBSCRIPTIONS FOR WEALTH MANAGEMENT PROD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nFWN3Y617D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"1139924115","title":"SKB BIO-B (06990) Subscribes to Financial Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1139924115","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139924115?lang=en_us&edition=fundamental","pubTime":"2026-01-06 20:58","pubTimestamp":1767704296,"startTime":"0","endTime":"0","summary":"SKB BIO-B (06990) announced that on January 6, 2026, the company entered into the Bank of China Structured Deposit Agreement II, under which it agreed to subscribe to a Bank of China Structured...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2601920358","title":"Sichuan Kelun-Biotech Biopharmaceutical Co Ltd -  Subscriptions for Wealth Management Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2601920358","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601920358?lang=en_us&edition=fundamental","pubTime":"2026-01-06 20:55","pubTimestamp":1767704118,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nFWN3Y617D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":122,"code":"91000000","status":"200"}]}}